Study Condition(s): Adult Type 2 Diabetes

A Study of LY3209590 in Participants With Type 2 Diabetes

Study Alias: BDCB

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT03367377 {{ currentLocaleObject.registryAnchorText }}

Withdrawn Active, not recruiting

Study Purpose

This study will evaluate the safety and tolerability of LY3209590 when given by injection under the skin to participants with type 2 diabetes. It will also investigate how the body processes the study drug and the effect of the study drug on blood sugar levels.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18 years
70 years

Time Commitment

Your participation could last about 17 weeks and include up to 10 visits to the study center.
  • Participant must have type 2 diabetes mellitus (T2DM) for at least 1 year

  • Participant must not have had any episodes of severe hypoglycemia (low blood sugar) in the past 6 months and blood sugar must be stable for 3 months prior to screening

  • Participant must not have any significant changes in insulin treatment within 3 months prior to screening

  • Participant must not have a history of kidney impairment

  • Participant must not have had a blood clot in the leg or have close family members (parents, siblings, or children) with repeated episodes of blood clots in the legs

  • Participant must not be using an insulin pump

  • Participant must not be taking degludec (Tresiba®) insulin therapy now or within the last 90 days

Where to Participate

5 locations are currently available of 5 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.